Impact of SARS-CoV-2 (COVID-19) Infection, Treated in Ambulatory Care, on Long-term Quality of Life in a Parisian Military Population

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT04893070

Acronym

COVIDAMBUCMA1

Enrollment

173

Registered

2021-05-19

Start date

2021-07-15

Completion date

2022-07-04

Last updated

2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Covid19, SARS-CoV2 Infection

Keywords

Quality of life

Brief summary

In April 2020, a meta-analysis on the long-term sequelae of respiratory syndromes related to seasonal coronaviruses (SARS and MERS) showed a significant alteration in quality of life, with in particular a decrease in physical and emotional capacities and a deterioration of social life. An improvement of the quality of life is evidenced after 6 months but without reaching the level usually observed in healthy people. The impact of SARS-CoV-2 infection on quality of life can be explained by the persistence of pleomorphic symptoms in the medium to long term. In the military population, the majority of SARS-CoV-2 cases present minor to moderate forms of the disease. Military personnel have living conditions that differ from those of the general population, in particular because of their geographic mobility, which may be responsible for isolation from the family. This isolation can be regular (we speak of geographical celibacy when the soldier is posted in a geographical area far from the family unit) and/or occasional, during missions on the national territory or outside. This singularity justifies a study on the impact of SARS-CoV-2 (COVID-19) infection on the quality of life in this specific population.

Interventions

OTHERQuestionnaires COVID+

* 1 questionnaire on COVID-19 symptomatology and quality of life 12 months after COVID-19 first symptoms * 1 questionnaire on quality of life 18 months after COVID-19 first symptoms

OTHERQuestionnaires COVID-

* 1 questionnaire on quality of life at enrollment * 1 questionnaire on quality of life 6 months after enrollment

Study design

Observational model

CASE_CONTROL

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Yes

Inclusion criteria

* Military personnel * COVID+: diagnosed with COVID-19 and managed in ambulatory care since March 14th, 2020 * COVID-: not having been infected with SARS-CoV-2

Exclusion criteria

* Hospitalized for COVID-19 * Having received a treatment against COVID-19 (other than paracetamol)

Design outcomes

Primary

Measure	Time frame	Description
Long-term quality of life (mental component)	18 months after COVID-19 first symptoms	Mental Component Score (MCS) of the SF-36 questionnaire. The MCS ranges from 0 (bad quality of life) to 100 (good quality of life).

Secondary

Measure	Time frame	Description
Long-term quality of life (physical component)	18 months after COVID-19 first symptoms	Physical Component Score (PCS) of the SF-36 questionnaire. The PCS ranges from 0 (bad quality of life) to 100 (good quality of life).

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026